Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations Meeting Abstract


Authors: Mhanna, L.; Milia, J.; Lusque, A.; Couraud, S.; Mascaux, C.; Veillon, R.; Frueh, M.; Moro-Sibilot, D.; Lattuca-Truc, M.; Tomasini, P.; Barlesi, F.; Drilon, A. E.; Gautschi, O.; Mazieres, J.
Abstract Title: Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations
Meeting Title: 2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 5 Suppl.
Meeting Dates: 2018 Jan 25-27
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-10
Language: English
ACCESSION: WOS:000436177700164
DOI: 10.1200/JCO.2018.36.5_suppl.172
PROVIDER: wos
Notes: Meeting Abstract: 172 -- Source: Wos
Altmetric Score
MSK Authors
  1. Alexander Edward Drilon
    132 Drilon